Kathleen Mazor to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Kathleen Mazor has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
0.676
-
Mazor KM, Andrade SE, Auger J, Fish L, Gurwitz JH. Communicating safety information to physicians: an examination of dear doctor letters. Pharmacoepidemiol Drug Saf. 2005 Dec; 14(12):869-75.
Score: 0.221
-
Singh S, Cocoros NM, Li X, Mazor KM, Antonelli MT, Parlett L, Paullin M, Harkins TP, Zhou Y, Rochon PA, Platt R, Dashevsky I, Massino C, Saphirak C, Crawford SL, Gurwitz JH. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PLoS One. 2024; 19(2):e0297562.
Score: 0.195
-
Walsh KE, Harik P, Mazor KM, Perfetto D, Anatchkova M, Biggins C, Wagner J, Schoettker PJ, Firneno C, Klugman R, Tjia J. Measuring Harm in Health Care: Optimizing Adverse Event Review. Med Care. 2017 04; 55(4):436-441.
Score: 0.121
-
Field TS, Tjia J, Mazor KM, Donovan JL, Kanaan AO, Harrold LR, Reed G, Doherty P, Spenard A, Gurwitz JH. Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approach. Am J Med. 2011 Feb; 124(2):179.e1-7.
Score: 0.079
-
Field TS, Mazor KM, Briesacher B, Debellis KR, Gurwitz JH. Adverse drug events resulting from patient errors in older adults. J Am Geriatr Soc. 2007 Feb; 55(2):271-6.
Score: 0.060